Mani, Inc.(MNICF)
USD --+0.00%
Reward50Moderate
Risk26Low
📊75%Data
Strong 18% profit margin · 2.4% dividend yield
MNICF
+0.0 · +0.00%
USD · PINK
Mani, Inc. | Healthcare
Defensive Anchor
Market Cap:1.26Bn
ℹ️
Reward Rating
50
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
26
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MNICF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Mani, Inc.?

engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally.

MNICF · Verdict

Moderate reward · low risk

MNICF stands out on volatility and cash flow, but watch the growth signal.

Based on 88% data coverage

MNICF · Verdict

What’s working & what to watch

Strengths 3

  • Volatility95/100

    Top decile vs peers

  • Cash flow77/100

    1% free-cash-flow margin

  • Profitability69/100

    15% net margin · 10% ROE

Watchouts 1

  • Growth41/100

    Rev +13.6% CAGR · earnings -4.3%

Model-based scoring. For information only — not financial advice.

What is Mani, Inc.?

engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.26B, and a P/E ratio of 30.5x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (50)

The scoring profile indicates limited reward potential at this time, with profitability and momentum offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.26B
P/E Ratio30.5238
Dividend Yield2.41%
52 Week High12.82
52 Week Low12.4132
Last AnnualAugust
IPO DateN/A
IncorporatedUSA
Shares Outstanding99M
No. of Employees4,140
IndustryMedical Instruments & Supplies
ExchangePINK
Beta0.184
CurrencyUSD · Reports in JPY